Previous close | 9.00 |
Open | 9.00 |
Bid | 4.30 |
Ask | 13.00 |
Strike | 240.00 |
Expiry date | 2024-09-20 |
Day's range | 9.00 - 9.00 |
Contract range | N/A |
Volume | |
Open interest | 14 |
Company Faces Decline in Life Sciences but Gains in Clinical Diagnostics
HERCULES, Calif., May 07, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2024.
National Vision (EYE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.